oxaliplatin - Generic mfg.
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Tyvyt (sintilimab) - Innovent Biologics, Eli Lilly
Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy (clinicaltrials.gov) - Oct 16, 2026 - P=N/A | N=15 | Completed | Sponsor: Chinese PLA General Hospital | N=28 ➔ 15 | Trial completion date: Jul 2024 ➔ Oct 2026 | Trial primary completion date: Jun 2024 ➔ Sep 2026 | Recruiting ➔ Completed 
Biomarker • Enrollment change • Trial completion • Trial completion date • Trial primary completion date • Gastric Adenocarcinoma • Gastric Cancer • Oncology • Solid Tumor
http://clinicaltrials.gov/ct2/show/NCT06202781
 
Oct 16, 2026
 
Prev Next